Skip to main content
. Author manuscript; available in PMC: 2012 Nov 28.
Published in final edited form as: Nat Rev Genet. 2011 Jul 12;12(8):529–541. doi: 10.1038/nrg3000

Table 1. EWAS power simulation.

(Number of
cases, number
of controls)
Power (%) to detect an MVP
Scenario a meth OR = 1.24
md = 3.6%
meth OR = 1.49
md = 7.2%
meth OR = 1.78
md = 10.8%
meth OR = 2.10
md = 14.4%
(100,100) 0 0 0 0 2 0 18 1
(200,200) 0 0 4 0 55 11 99 78
(400,400) 1 0 66 21 100 98 100 100
(800,800) 20 3 100 99 100 100 100 100
Scenario b meth OR = 1.24
md = 3.6%
meth OR = 1.49
md = 7.2%
meth OR = 1.78
md = 10.8%
meth OR = 2.10
md = 14.4%
(100,100) 0 0 1 0 13 1 60 19
(200,200) 0 0 16 2 84 46 100 97
(400,400) 2 0 85 51 100 100 100 100
(800,800) 33 8 100 100 100 100 100 100
Scenario c meth OR = 1.27
md = 1.25%
meth OR = 1.54
md = 2.5%
meth OR = 1.82
md = 3.75%
meth OR = 2.11
md = 5.0%
(100,100) 1 0 37 10 95 77 100 99
(200,200) 7 1 95 78 100 100 100 100
(400,400) 50 19 100 100 100 100 100 100
(800,800) 98 88 100 100 100 100 100 100

Power (%) to detect an MVP at α = 10−6 (left entry in each cell) and α = 10−8 (right entry) for the sample sizes stated in column 1 under scenarios (a), (b) and (c) of Figure 2. methOR = methylation odds ratio, the odds for a random DNA strand in the tissue sample from a random case to be methylated, divided by the same odds for controls; md = difference in mean methylation rate between cases and controls. Analysis is via a Wald test in logistic regression implemented in the R software.